Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Sayah N, Bhatt DL, Miller M, Brinton EA, et al. Eur Heart J 2024;45:1173-1176.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sayah N, Bhatt DL, Miller M, Brinton EA, et al. Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial. Eur Heart J 2024;45:1173-1176.
PMID: 38252107